HIGHLIGHTS
- who: MarĂa-Soledad Valera from the DrsX.-J. Yang and N. R. Bertos (Molecular Oncology Group, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada) kindly provided all , constructs used in the present study [56]. When indicated, these plasmids were cloned into pEGFP-, (Clontech, Palo Alto, CA, USA) or, terminal tagged with the terminal influenza hemagglutinin (HA) epitope. The pcDNA3., (Life Technologies) or pEGFP-, (Clontech) vectors were used as a control of cDNA transfection or to express free EGFP, respectively. APOBEC G (A G) was kindly provided by Dr. B. R. Cullen (Duke University, USA . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.